and IV. These enzymes, although highly conserved in amino acid sequence, differ in molecular mass, tissue distribution, regulation and catalytic properties. HKI-111 have molecular masses of approx. 100 kDa, show a broad but distinct tissue distribution, have a relatively high affinity for glucose, and are subject to feedback regulation by physiological levels of glucose 6-phosphate (G6P) [l] . HKIV, more commonly referred to as glucokinase (GK), has a molecular mass of approx. 50 kDa, is primarily located in liver and pancreatic p-cells, has a lower affinity for glucose, and is not subject to feedback regulation by physiological levels of G6P [2] . T h e difference in molecular mass between G K and Abbreviations used: CRE, CAMP-respondent element; G6P, glucose 6-phosphate; GK, glucokinase; HK, hexokinase; NIDDM, non-insulin-dependent diabetes mellitus. *To whom correspondence should be addressed. Glucose enters cells through a specific member of a family of glucose transporters, designated GLUT1-4 [6] . T h e phosphorylation of glucose by the HKs ensures glucose entry into cells through members of the glucose-transporter family via facilitated diffusion along a downhill concentration gradient, and thus HK provides the 'pull' for glucose entry into the cell.
T h e tissue distribution of the various HK family members, intracellular location and relationship to glucose transporters, mechanism of action and regulation are all of interest. In this regard, we chose to focus our studies on the HK isoenzyme HKII and present here a summary of the information we have obtained about the structure of the gene, the regulation of the gene, the protein structure and the role of HKII in glucose metabolism.
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HKll mRNA and gene structure
The entire rat mRNA sequence was deduced from the analysis of complementary and genomic DNA fragments [7] . The mRNA contains a 275 1-nucleotide open reading frame that encodes a protein of 102550 Da. Transcripts of approx. 5500 and 4400 nucleotides are produced from a single transcription-initiation site as there are two alternative termination sites. These transcripts thus contain 462 nucleotides of 5'-noncoding sequence, the coding sequence, and either 11 14 or 2142 nucleotides of 3'-non-coding sequence. A poly(A) tail of average length would account for the rest of each mRNA molecule [7] .
The human HKII gene is located on chromosome 2, band p13.1 as determined by fluorescence in situ hybridization [8] . The characterization of a (TA), polymorphism in intron 12 of the human HKII gene, and multipoint linkage analysis of Centre d'Etude Poymorphisme Humain family genotypes with other chromosome 2 markers, showed that the most likely locus order is cen-D2S169-[D2S286-tel [9] . The structures of the human and rat HKII genes and gene products are very similar [7, 10] . Both genes are at least 50 kb in length and have 18 exons ranging in size from 96 to 2536 bp; exons 2-17 of the rat gene are identical in size with those of the human gene. The mRNAs have the same general structure and each encodes a protein consisting of 917 amino acids. There is 87% identity of the nucleotide sequence between the human and rat HKII genes in the open reading frame, and 94% identity of the amino acid sequence of the proteins. This high degree of sequence conservation between rat and human is typical for a given member of the HK family, and is indicative of the fact that these enzymes have diverged very little.
HKll pseudogene
An intronless pseudogene was obtained during the isolation of the HKII gene from a human genomic library [ll] . This genomic DNA sequence is similar to a cDNA copy of human HKII mRNA, as it contains 2734 bp of sequence that is 97% identical with the open reading frame of the mRNA. The pseudogene sequence does not maintain an open reading frame that could encode a functional HK. Sequences similar to the 5' and 3' untranslated regions of human HKII mRNA show 96 and 95% sequence identity respectively. An A-rich sequence is located 3' from the point at which the similarity between the human HKII mRNA and the pseudogene ceases, and a 10 bp direct repeat flanks both ends of this processed HKII pseudogene. The HKII pseudogene is estimated to have integrated into a long interspersed nuclear repetitive DNA element located on the X chromosome, about 14-16 million years ago, which agrees with its absence from the rat genome [ 111.
HKll gene evolution and protein structure Several investigators postulated that the 100 kDa HKs evolved from a 50 kDa GK-like precursor by duplication and tandem ligation of an ancestral gene [3-51. The high degree of similarity in the amino acid and nucleotide sequences of the rat and human GK and HKII proteins and genes, and a comparison of the structures of the GK and HKII genes, supports this hypothesis [1, 2] . An examination of the coding regions of the GK and HKII genes (which excludes parts of the first and last exons) revealed a remarkable conservation of the sizes of the exons between GK and those that encode both the N-and C-terminal halves of HKII [7] . The exons of the N-and C-terminal halves of HKII and exons 2-10 of GK are all exactly conserved in size, with the exception of exon 3. Exons 3 and 11 in the HKII gene (both of which correspond to exon 3 in the GK gene) are the same size. Most revealing is exon 10 in HKII. This 305 bp exon apparently arose from a fusion of the tenth exon (142 bp) of one precursor with the second exon (163 bp) from a secondary copy of the precursor. These observations strongly suggest that HKII arose from the duplication and tandem ligation of a precursor gene with a structure similar to that of GK (see Figure 1 ). Given the high degree of sequence conservation within and between HK family members, the HKI and HKIII genes probably have similar structures.
Kinetic analysis of HKI suggests that the 100 kDa hexokinases could have evolved from the duplication and tandem ligation of a gene that encodes a 50 kDa G6P-sensitive HK El]. The C-terminal half of HKI, expressed as a separate 50 kDa protein, is active and sensitive to G6P inhibition. The expressed N-terminal half of HKI is inactive; however, in the intact enzyme it is thought to contain the G6P-regulatory site [ 13. Therefore, as a consequence of the duplication Volume 25 process, the G6P-regulatory site in the C-terminal half and the catalytic site in the N-terminal half of the 100 kDa HKs were thought to be lost or masked, rather than simply duplicated. Quite different results were obtained from an analysis of HKII (see Figure 1 and [12] ). Proteins consisting of either the N-or C-terminal half of human or rat HKII have catalytic activity and each half is inhibited by G6P. Mutations of either Asp-209 or Asp-657 of HKII completely abolish the catalytic activity of either the N-or C-terminal half enzyme respectively. Mutation of either of these amino acids in the intact enzyme results in an approx. 50% reduction in activity. Mutation of both amino acids results in a complete loss of activity. Thus, the N-and C-terminal halves of HKII both have catalytic activity. In addition, the N-and C-terminal half proteins of HKII are both sensitive to G6P inhibition, but the Cterminal half protein is inhibited at much higher concentrations of G6P than is the N-terminal half or intact HKII (see Figure 1) . It is possible that these different kinetic properties allow intact HKII to play a unique role in glucose metabolism under various physiological conditions.
Regulation of the HKll gene
The hexokinases and the various members of the family of facilitative glucose transporters are essential partners in the important process of glucose uptake and utilization in all cells. Glucose uptake occurs constitutively in many tissues, but in certain examples, such as liver, adipose tissue, and skeletal muscle, this process is regulated. The expression of the glucose transporters (GLUTl, GLUT2 and GLUT4) and the hexokinases (HKI, HKII and GK) was analysed in insulin-sensitive tissues (skeletal muscle, brown adipose tissue and liver) during development of the rat [13] . GLUTl and HKI are the major isoforms in fetal muscle. About postnatal day 5, when skeletal muscle begins to differentiate and acquire contractile acitvity, GLUTl and HKI are replaced by GLUT4 and HKII. In brown adipose tissue GLUT4 and HKII are the major isoforms present from fetal were not observed. Liver has GLUTl and HKI as the major isoforms until about day 14 when GLUT2 and GK appear, and the latter are dominant in adult life. Thus in fetal tissues GLUTl and HKI are the major isoforms, which is in accordance with constitutive glucose utilization and low sensitivity of fetal tissues to insulin. The presence of GLUT4 and HKII in brown adipose tissue may relate to their role to increase glucose utilization for thermogenesis, a process that is critical for survival of the newborn. Regulated glucose utilization in adult skeletal muscle involves GLUT4 and HKII, and in liver, GLUT2 and GK. These observations suggest that a functional coupling may exist between various pairs of transporters and HKs to meet specific demands of glucose utilization during development and in the subsequent regulation of glucose utilization. The manner in which these two steps are coupled by the intracellular glucose concentration, and the effects of hormonal and nutritional alterations in this coupling, is likely to be crucial in determining glucose utilization in a particular tissue. As an initial step to the examination of these possibilities, the regulation of GLUT4 and HKII was investigated under different metabolic conditions to determine whether the two genes are expressed co-ordinately or whether selective alterations of HKII gene expression account for some or all of the changes observed in glucose utilization.
In a study involving 6 and 24 h euglycaemic-hyperinsulinaemic and hyperglycaemichyperinsulinaemic clamps in rats, insulin induced adipose tissue GLUT4 and HKII mRNA and protein [14] . In contrast, GLUT4 mRNA was unaffected in skeletal muscle, but HKII mRNA was induced, and corresponding amounts of GLUT4 protein and HKII enzyme activity were measured. Thus hyperinsulinaemia has a m-ordinated effect on GLUT4 and HKII in adipose tissue, but causes a selective induction of HKII in skeletal muscle. The plasma glucose level did not affect GLUT4 or HKII expression in these clamp studies. HKII mRNA is also increased about 3-fold in human skeletal muscle after a 3 h infusion of insulin during a euglycaemic clamp, a treatment that has no effect on HKI, GLUT4 and glycogen synthase mRNA [15] .
The effect of temperature on HKII gene expression was analysed in newborn rats that were starved and placed for 24 h at either 20 "C (cold exposure) or 37 "C (thermoneutrality) [13] . GLUT4 and HKII mRNA were increased 2-4-fold in brown adipose tissue of the rats exposed to the cold temperature. Cold stress induced HKII gene expression in starved newborn rats, a condition in which insulin levels are low, so another factor may be involved.
Rat skeletal-muscle HKII gene transcription, mRNA and activity are increased after an acute bout of exercise [16, 17] . Thirty minutes of treadmill exercise, with a 3 h recovery, increases HKII mRNA to the same extent as exhaustive exercise, but 15 min of exercise had no effect. GLUT4 and HKI mRNA were not affected by an acute bout of exercise. The level of basal HKII mRNA and activity, and the induction seen with exercise, is dependent on the skeletal-muscle fibre types, as slow-twitch oxidative fibres have higher basal levels and a larger induction of HKII gene expression than do fast-twitch glycolytic fibres. In addition to exercise and cold stress, catecholamines (P-adrenergic agonists) increase HKII activity in rat or mouse brown adipose tissue and muscle [18-211. Insulin induces HKII mRNA in two adipose cell lines (33-F442A and BFCLlB) and two skeletal-muscle cell lines (C2C12 and L6) [7] . In L6 cells this increase was accounted for by a corresponding increase in HKII gene transcription. Isoprenaline and CAMP also selectively increase HKII gene transcription in L6 cells [22] . Propranolol, a P-adrenergic antagonist, prevents the isoprenaline-mediated increase in HKII gene transcription. These increases in HKII gene transcription by insulin and isoprenaline result in corresponding increases in HKII mRNA, the rate of synthesis of the protein and glucose utilization. L6 cells, unlike skeletal muscle, have low amounts of the insulin-regulated GLUT4 transporter and high levels of the GLUTl transporter. The maximal basal rate of glucose transport markedly exceeds glucose utilization in these cells, thus increased glucose phosphorylation by hormone-induced gene expression of HKII results in the observed increase in glucose utilization.
The co-ordinated regulation of GLUT4 and HKII appears to be an essential component of glucose utilization in skeletal muscle and fat tissues. Insulin promotes the rapid translocation of GLUT4 to the plasma membrane and then stimulates the rate of transcription of the HKII gene, and this combination results in enhanced Volume 
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glucose utilization. This important control mechanism plays a key role in glucose homoeostasis because, under certain hormonal and metabolic conditions, transport is rate-limiting in these tissues, whereas in other instances glucose phosphorylation is rate-limiting [23-271. An understanding of how HKII gene expression is altered will provide insight into how the cell regulates glucose utilization. Two different signal-transduction pathways appear to be involved in insulin-regulated glucose utilization. GLUT4 translocation is regulated by a phosphatidylinositol 3-kinase-dependent rapamycin-insensitive pathway . HKII gene expression is regulated by a rapamycin-sensitive phosphatidylinositol 3-kinaselp70 S6 protein kinasedependent pathway [ 3 13 . The complete pathway for either insulin-regulated GLUT4 translocation or HKII gene expression remains to be determined.
A more detailed analysis of HKII gene induction by insulin or catecholamines (via CAMP) was undertaken in L6 cells to gain further insight into these two distinct responses [31, 32] . The HKII promoter was analysed using the transient transfection approach, and specific DNA-protein interactions were examined by electrophoretic mobility-shift assays. The basal promoter consists of about 160 bp of 5'-flanking sequence that includes a Y box, a CCAAT box and a CAMP-response element (CRE). The CCAAT box and the CRE are both involved in the CAMP response. The CCAAT and Y boxes bind the transcription factor known as NF-Y [33, 34] , whereas the CRE binds the CRE-binding protein and activating transcription factor 1 [ 35,361. Together these transcription factors appear to play an important role in both basal and CAMP-induced expression of the rat HKII gene. The specific DNA elements and the proteins involved in the induction of the HKII promoter by insulin have not yet been identified, but about 500 bp of 5'-flanking sequence contains all the sequences required for this induction [31] .
HKll and diabetes
Non-insulin-dependent diabetes mellitus (NIDDM) affects 4-596 of the population in most countries and a similar percentage of individuals is at risk of developing this disease [37, 38] . Decreased peripheral utilization of glucose is a prime feature of this disease. From a quantitative point of view, skeletal muscle is the major tissue involved in this process, and in NIDDM this tissue is resistant to the action of insulin. Skeletal-muscle glycolysis is normal early in NIDDM, but glycogen deposition is abnormal. Although evidence for abnormalities in glycogen synthase have been reported, a recent paper noted that basal G6P levels, measured in vivo by 31P NMR, were relatively low in patients with NIDDM, and were not normally increased by insulin [39] . This could be because less glucose is transported (a GLUT4 defect), or because there is decreased phosphorylating activity (an HKII defect). Quantification of in vivo rates of glucose transport and intracellular phosphorylation showed that both a defect in transport and phosphorylation exists, and the latter is quantitatively more severe [40] . There is great interest in defining the exact causes of these defects, since this might direct attention to the gene(s) involved and could provide the basis for a therapeutic strategy. A link between NIDDM and mutations of the HKII gene was not found [9, , but some defect in HKII regulation or action is a possible explanation of these observations. Indeed, HKII gene expression is impaired in skeletal muscle isolated from persons with NIDDM [44] , although the precise role of HKII in NIDDM remains to be clarified.
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